nasdaq:alny

Alnylam Pharmaceuticals: The Winning Streak Continues (ALNY)

Published on Wed, 05/22/2013 - 14:19
By Peter Chu in 52 Week high-lows, ALNY, 52 week high/lows, alnylam pharmaceuticals, nasdaq:alny
ALNY

By Peter Chu
pchu@fnno.com

Stock Investors Bid Up Shares of Alnylam Pharmaceuticals, Up 3.2%

Published on Wed, 05/22/2013 - 10:19
By Adrienne Chilton in Market movers, ALNY, alnylam pharmaceuticals, market movers, nasdaq:alny
ALNY

By Adrienne Chilton
achilton@fnno.com

Alnylam Pharmaceuticals Earnings Review: 12 Days after Announcement Shares Up 15.8% (ALNY)

Published on Sat, 05/18/2013 - 09:26
By Peter Chu in Earnings Lookback, ALNY, alnylam pharmaceuticals, earnings flashbacks, nasdaq:alny
ALNY

By Peter Chu
pchu@fnno.com

Stock Investors Sell Off Shares of Alnylam Pharmaceuticals, Down 2.7%

Published on Thu, 05/16/2013 - 12:19
By Mallory Stone in Market movers, ALNY, alnylam pharmaceuticals, market movers, nasdaq:alny
ALNY

By Mallory Stone
mstone@fnno.com

Alnylam Pharmaceuticals Looks to Continue to Trade Above its Annual-High Share Price Today

Published on Mon, 05/13/2013 - 14:14
By Mallory Stone in 52 Week high-lows, ALNY, 52 week high/lows, alnylam pharmaceuticals, nasdaq:alny
ALNY

By Mallory Stone
mstone@fnno.com

Trading Higher on Heavy Volume are Shares of Alnylam Pharmaceuticals on 1.7x Above-Average Volume (ALNY)

Published on Mon, 05/13/2013 - 13:11
By Adrienne Chilton in Unusual volume, ALNY, alnylam pharmaceuticals, nasdaq:alny, unusual volume
ALNY

By Adrienne Chilton
achilton@fnno.com

Alnylam Pharmaceuticals Shares Climbing Higher, Up 5.2%

Published on Mon, 05/13/2013 - 10:15
By Robert Cotter in Market movers, ALNY, alnylam pharmaceuticals, market movers, nasdaq:alny
ALNY

By Robert Cotter
rcotter@fnno.com

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (ARNA, RGEN, ALNY, EXAS, ARIA)

ARNA

By Robert Cotter
rcotter@fnno.com

Best Relative Performance in the Biotechnology Industry Detected in Shares of Arena Pharmaceuticals (ARNA, RGEN, ALNY, EXAS, ARIA)

ARNA

By Mallory Stone
mstone@fnno.com

Arena Pharmaceuticals has the Best Relative Performance in the Biotechnology Industry (ARNA, RGEN, ALNY, EXAS, ARIA)

ARNA

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Shares of Exeter Resource Have Fallen Be...

Shares of Exeter Resource (AMEX:XRA) traded at a new 52-week low today of $0.69. Appro ...

Shares of Vale Have Fallen Below Previou...

Shares of Vale (NASDAQ:VALE) traded today at $15.37, breaking its 52-week low. This ne ...

Shares of Toro Rise Above Previous 52-We...

Toro (NYSE:TTC) traded at a new 52-week high today of $49.38. So far today approximate ...

Shares of Synopsys Rise to a New 52-Week...

Shares of Synopsys (NASDAQ:SNPS) traded at a new 52-week high today of $36.29. Approxi ...

Stein Mart Looks to Continue to Trade Ab...

Stein Mart (NASDAQ:SMRT) traded at a new 52-week high today of $12.09. This new high w ...

Pacific Sunwear: 52-Week High Recently E...

Pacific Sunwear (NASDAQ:PSUN) traded today at a new 52-week high of $3.45. This new hi ...

Recent 52-Week High Exceeded in Shares o...

Shares of Pfsweb (NASDAQ:PFSW) traded today at $4.60, breaking its 52-week high. So fa ...

Shares of NextEra Energy Fall Below Prev...

Shares of NextEra Energy (NYSE:NEE) traded today at $30.37, breaking its 52-week low. ...

Most Popular Video News